Sign in
4

Changes in Ownership

Royalty Pharma plc Filed Acc 0001814876-26-000002

EVP & CFO sold 69,582 shares at $38.42 ($2,673,041)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Coyne Terrance P. · EVP & CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-02 Sale : show line 1 in the form 10b5-1 −65,832 $38.42 $2,528,982 460,828 I
2026-01-02 Sale : show line 2 in the form 10b5-1 −3,750 $38.42 $144,059 39,760 I
Open-market sales · 69,582 sh · avg $38.42 · $2,673,041
Loading xslF345X05/wk-form4_1767734318.xml…